Vireo Approved for NY’s First-Ever Medical Marijuana Home Delivery Program
Eight County Delivery Zone to include all Five New York City Boroughs, Long Island and Westchester
New York, NY – Today, Vireo Health of New York (“Vireo”), one of only five companies licensed by New York State to cultivate, manufacture and dispense medical marijuana, announced that it received approval from the New York State Department of Health to launch a medical marijuana home delivery program.
The medical marijuana ‘from our greenhouse to your front door’ home delivery program was designed by a team of security experts, pharmacists and physicians to serve homebound patients with life-threatening and debilitating diseases, like Cancer and ALS. Initially, deliveries will cover an eight-county zone, including all five New York City Boroughs, Long Island and Westchester.
Numerous measures have been taken to ensure the safety of patients and the delivery staff. In accordance with State regulations that prohibit outsourcing in New York’s ‘seed-to-sale’ medical marijuana industry, all deliveries will be handled exclusively by Vireo employees. The deliveries will be handled by at least two employees, and company-owned delivery vehicles will be outfitted with cutting-edge safety features, including GPS tracking devices.
“New Yorkers have increasingly come to expect home delivery and we plan on leveraging ‘last mile’ supply chain technologies to meet and exceed patient expectations,” said Ari Hoffnung, CEO of Vireo Health of New York. “We are grateful to the State’s public health and safety officials for their help making this Compassion Care Act program a reality.”
“Day-in and day-out our goal at Vireo Health of New York is to provide the best possible care and service to our patients,” said Dr. Stephen Dahmer, Vireo Health’s Chief Medical Officer. “Home delivery will not only help us to improve upon current services, but also expand our reach to those patients who are unable to travel. Our team is excited to provide this service to all of our existing patients, and to have the opportunity to meet new patients in other parts of the state.”
The Company plans to launch the program within 90 days. Delivery pricing and other details will be released over the coming weeks. Certified patients or family members of patients interested in receiving more information can sign-up for home delivery program updates by visiting: www.vireohealth.com/ny/delivery.
About Vireo Health of New York
Vireo Health of New York is a physician-led company dedicated to providing best-in-class cannabis-based medications and top quality patient care. The company provides a wide array of pharmaceutical grade cannabis-based products formulated from the highest quality plants and utilizes its separation chemistry capabilities to create products with novel cannabinoid combinations. Vireo Health of New York is a wholly owned subsidiary of Vireo Health, LLC. For more information, visit http:/www.vireohealth.com/ny.